Rock Springs Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-107,630
| Closed | -$155K | – | 154 |
|
|
2017
Q3 | $155K | Sell |
107,630
-58,075
| -35% | -$83.6K | 0.01% | 147 |
|
|
2017
Q2 | $268K | Buy |
165,705
+3,634
| +2% | +$5.88K | 0.01% | 147 |
|
|
2017
Q1 | $552K | Buy |
162,071
+114,571
| +241% | +$390K | 0.03% | 138 |
|
|
2016
Q4 | $247K | Sell |
47,500
-8,750
| -16% | -$45.5K | 0.02% | 133 |
|
|
2016
Q3 | $1.42M | Hold |
56,250
| – | – | 0.09% | 127 |
|
|
2016
Q2 | $1.39M | Hold |
56,250
| – | – | 0.1% | 123 |
|
|
2016
Q1 | $1.63M | Buy |
56,250
+8,750
| +18% | +$253K | 0.14% | 118 |
|
|
2015
Q4 | $1.76M | Sell |
47,500
-2,500
| -5% | -$92.8K | 0.13% | 110 |
|
|
2015
Q3 | $2.44M | Sell |
50,000
-8,750
| -15% | -$426K | 0.2% | 107 |
|
|
2015
Q2 | $4.05M | Buy |
58,750
+5,625
| +11% | +$388K | 0.3% | 101 |
|
|
2015
Q1 | $1.9M | Buy |
+53,125
| New | +$1.9M | 0.18% | 99 |
|